Volpi Group Video

See how Volpi can help you to reduce complexity for design, development, and manufacturing of smart optical module solutions for in vitro diagnostics (IVD) and life sciences instruments. Read More »

White paper: Point of Care Testing

Simplifying market access for Point of Care solution providers Given increased interest in areas such as antimicrobial resistance (AMR) and viral/bacterial patient stratification, Point of Care Testing (POCT) has recently attracted a lot of attention. With the entry of large diagnostic solution providers in the POCT market, a strong competition on market shares can be Read More »

Volpi’s Offering in the Field of OEM qPCR-Measurement Systems

The challenges Quantitative polymerase chain reaction or qPCR, sometimes called real-time PCR, simultaneously detects and measures the amount of a specific DNA target in a sample by amplifying that target during cycles of heating and cooling the sample. Since its development in the early 1990s, qPCR has become an essential part of many molecular diagnostic Read More »

Fluorescence Calibration Tools

The challenge Many IVD assays and devices rely on fluorescence emission and detection. This is particularly true in the field of molecular diagnostics, where real-time PCR and other instruments that detect and process fluorescent dye signals are used every day in both research and clinical laboratories. Calibration of fluorimeters in in vitro diagnostic (IVD) devices Read More »

Volpi USA ISO 13485 Certification Announcement

AUBURN, USA, Oct. 28, 2016 The Volpi Group today announced that its U.S. branch has earned ISO 13485 certification. The certification demonstrates that Volpi USA has met the highest international standard for quality management systems used in the design and manufacture of medical devices.  Volpi USA’s ISO 13485 certification complements the same accreditation achieved by its Swiss Read More »

Volpi Group partners with QIAGEN to manufacture the imaging module for the GeneReader NGS platform

SCHLIEREN, Switzerland, Feb. 8, 2016 The Volpi Group, a 60-year-old optical electronics firm based in Schlieren, Switzerland, today announced that it is collaborating with QIAGEN Instruments AG on the manufacture of the automated fluorescence imaging module used in QIAGEN’s GeneReaderTM next-generation sequencing (NGS) instrument. The benchtop GeneReader combines with other QIAGEN NGS products to provide Read More »